JP2022549915A5 - - Google Patents

Info

Publication number
JP2022549915A5
JP2022549915A5 JP2022519458A JP2022519458A JP2022549915A5 JP 2022549915 A5 JP2022549915 A5 JP 2022549915A5 JP 2022519458 A JP2022519458 A JP 2022519458A JP 2022519458 A JP2022519458 A JP 2022519458A JP 2022549915 A5 JP2022549915 A5 JP 2022549915A5
Authority
JP
Japan
Application number
JP2022519458A
Other languages
Japanese (ja)
Other versions
JP2022549915A (ja
JPWO2021067261A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/053258 external-priority patent/WO2021067261A1/en
Publication of JP2022549915A publication Critical patent/JP2022549915A/ja
Publication of JPWO2021067261A5 publication Critical patent/JPWO2021067261A5/ja
Publication of JP2022549915A5 publication Critical patent/JP2022549915A5/ja
Priority to JP2025138126A priority Critical patent/JP2026004279A/ja
Pending legal-status Critical Current

Links

JP2022519458A 2019-09-30 2020-09-29 ノッティン-免疫刺激剤複合体ならびに関連組成物および方法 Pending JP2022549915A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025138126A JP2026004279A (ja) 2019-09-30 2025-08-21 ノッティン-免疫刺激剤複合体ならびに関連組成物および方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962908305P 2019-09-30 2019-09-30
US62/908,305 2019-09-30
PCT/US2020/053258 WO2021067261A1 (en) 2019-09-30 2020-09-29 Knottin-immunostimulant conjugates and related compositions and methods

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025138126A Division JP2026004279A (ja) 2019-09-30 2025-08-21 ノッティン-免疫刺激剤複合体ならびに関連組成物および方法

Publications (3)

Publication Number Publication Date
JP2022549915A JP2022549915A (ja) 2022-11-29
JPWO2021067261A5 JPWO2021067261A5 (https=) 2023-10-03
JP2022549915A5 true JP2022549915A5 (https=) 2023-10-03

Family

ID=75337493

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022519458A Pending JP2022549915A (ja) 2019-09-30 2020-09-29 ノッティン-免疫刺激剤複合体ならびに関連組成物および方法
JP2025138126A Pending JP2026004279A (ja) 2019-09-30 2025-08-21 ノッティン-免疫刺激剤複合体ならびに関連組成物および方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025138126A Pending JP2026004279A (ja) 2019-09-30 2025-08-21 ノッティン-免疫刺激剤複合体ならびに関連組成物および方法

Country Status (8)

Country Link
US (1) US20220257785A1 (https=)
EP (1) EP4037709A4 (https=)
JP (2) JP2022549915A (https=)
KR (1) KR20220071225A (https=)
CN (1) CN114585382A (https=)
AU (1) AU2020357806A1 (https=)
CA (1) CA3156165A1 (https=)
WO (1) WO2021067261A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102726248B1 (ko) 2016-07-07 2024-11-05 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 항체-애쥬번트 접합체
EP3774986A1 (en) 2018-04-13 2021-02-17 Massachusetts Institute of Technology Brush prodrugs and uses thereof
AU2020241686A1 (en) 2019-03-15 2021-11-04 Bolt Biotherapeutics, Inc. Immunoconjugates targeting HER2
CN113891731A (zh) * 2019-05-22 2022-01-04 小利兰·斯坦福大学理事会 药物缀合物及其使用方法
KR20220085791A (ko) * 2019-10-16 2022-06-22 메사추세츠 인스티튜트 오브 테크놀로지 브러시 전구약물 및 그의 용도
WO2025103490A1 (en) * 2023-11-16 2025-05-22 Beijing Changping Laboratory N-oxide immune agonists activation by radiotherapy
WO2025193946A2 (en) * 2024-03-14 2025-09-18 Genentech, Inc. Peptides binding lrrc15 and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2638173B1 (en) * 2010-11-08 2019-06-19 The Board of Trustees of The Leland Stanford Junior University Fusion proteins comprising an engineered knottin peptide and uses thereof
WO2014063012A1 (en) * 2012-10-19 2014-04-24 The Board Of Trustees Of The Leland Stanford Junior University Conjugated knottin mini-proteins containing non-natural amino acids
WO2014201245A1 (en) * 2013-06-12 2014-12-18 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Tlr-9 agonist with tlr-7 and/or tlr-8 agonist for treating tumors
JP6800141B2 (ja) * 2014-08-12 2020-12-16 マサチューセッツ インスティテュート オブ テクノロジー Il−2およびインテグリン結合性fc融合タンパク質による相乗的な腫瘍処置
US10888603B2 (en) * 2016-02-12 2021-01-12 The Board Of Trustees Of The Leland Stanford Junior University Methods of treating cancer cells expressing tumor-associated integrins
US10765625B2 (en) * 2016-03-15 2020-09-08 The Board Of Trustees Of The Leland Stanford Junior University Knottin-drug conjugates and methods of using the same
MX2019012295A (es) * 2017-04-14 2020-02-07 Tollnine Inc Polinucleotidos inmunomoduladores, conjugados de anticuerpos de los mismos y metodos para su uso.
CN113891731A (zh) * 2019-05-22 2022-01-04 小利兰·斯坦福大学理事会 药物缀合物及其使用方法
US20230211001A1 (en) * 2020-07-30 2023-07-06 The Board Of Trustees Of The Leland Stanford Junior University Lysosomal Targeting Molecules Comprising Knottin Peptides And Related Compositions And Methods

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
JP2022552416A5 (https=)
BR112021014123A2 (https=)
JP2022549915A5 (https=)
CL2025003481A1 (es) Anticuerpos anti-cd20 y estructuras car-t
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR112023016292A2 (https=)
BR112023011539A2 (https=)
BR112023011610A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)
BR102021016375A2 (https=)